[1] |
Rhodes KS,Weintraub M,Marchlewicz EH,et al.Medical nutrition therapy is the essential cornerstone for effective treatment of"refractory"severe hypertriglyceridemia regardless of pharmaceutical treatment:evidence from a lipid management program[J].J Clin Lipidol,2015,9(4):559-567.
|
[2] |
Amariles P,Sabater-Hernández D,García-Jiménez E,et al.Effectiveness of dader method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk:EMDADER-CV randomized controlled trial[J].J Manag Care Pharm,2012,18(4):311-323.
|
[3] |
虞燕霞,朱莉红,唐莲,等.药学服务干预对高脂血症患者用药依从性、治疗效果及颈动脉粥样斑块的影响分析[J].中国药学杂志,2014,49(19):1760-1765.
|
[4] |
Rai AK,Debetto P,Sala FD.Molecular regulation of cholesterol metabolism:HDL-based intervention through drugs and diet[J].India J Exp Biol,2013,51(11):885-894.
|
[5] |
Xu QY,Liu YH,Zhang Q,et al.Metabolomic analysis of simvastatin and fenofibrate intervention in high-lipid diet-induced hyperlipidemia rats[J].Acta Pharmacol Sin,2014,35(10):1265-1273.
|
[6] |
颜文,王淑琼,薛琴,等.应用Morisky服药依从性量表调查中存在的问题及对策[J].护理研究,2015,29(3):890.
|
[7] |
朱秀芳.临床药师不合理用药的药学干预分析[J].临床合理用药杂志,2016,33(6):331-335.
|
[8] |
赵喜荣,王旭东,胡东梅,等.高脂血症治疗用药及风险评估现状[J].解放军医药杂志,2013,25(7):90-94.
|
[9] |
韩立波,汪淑英.30例高脂血症患者临床治疗分析[J].中国卫生标准管理,2014,5(24):106-107.
|
[10] |
Huang LZ,Zhu HB.Novel LDL-oriented pharmacotherapeutical strategies[J].Pharmacol Res,2012,65(4):402-410.
|
[11] |
万红松,黄奎,戴娟,等.探索跟踪式药学服务对高脂血症患者自我管理水平的影响[J].中国药事,2015,29(11):1219-1222.
|
[12] |
高天曙,赵玉瑶,魏征,等.积雪草苷对高脂饲料诱导的肥胖小鼠降脂作用研究[J].中华中医药杂志,2016,31 (1):279-285.
|
[13] |
王柯静,陈琳.临床药师干预宫腔镜手术围术期抗菌药物使用效果分析[J].中国药房,2016,27(5):691-694.
|
[14] |
刘宇,邱峰,张涛,等.癌痛管理中规范化临床药学服务模式的建立及应用[J].中国医院药学杂志,2016,3(2):161-167.
|
[15] |
胡明光.药师针对临床不合理用药现象的药学干预措施分析[J].北方药学,2016,2(3):12-18.
|